CLIA-Validated Human Immune Profiling Panels
Clinical trials grade immunophenotyping with 40+ marker panels
Identify immune biomarkers for dose selection, mechanism of action, and pharmacodynamic studies in your clinical trials.
Accurate subset measurements with <20% coefficient of variation for all major immune cell types. Cellular markers of activation and exhaustion allow for detection of 790+ distinct immune subsets and states.
Need to track a program-specific marker or engineered cell therapy? Check out our Customizable Panels.
Whole Blood
Mass Cytometry
Up to 756 immune cell subsets and states, 42 markers, 1-3 week turnaround, starting at $1,350 per sample.
TokuKit compatible – for simplified sample collection and deep immune profiling of peripheral blood.
PBMC
Mass Cytometry
Up to 792 immune cell subsets and states, 42 markers, 1-3 week turnaround, starting at $1,350 per sample.
Analysis of non-granulocyte populations including T cell, B cell, NK cell, Monocytes, and Dendritic cell subsets and states.
PBMC
Spectral Flow Cytometry
Up to 245 immune cell subsets and states, 25 markers, 1-3 week turnaround, starting at $1,250.
Lower sample volume requirements, faster throughput for projects with large sample numbers.
Expertly Designed Human Pan-Immune Whole Blood Panel
The TokuProfile Standard Human Pan-Immune Whole Blood panel includes:
- Markers to identify every major immune cell population and subsets
- Expression of key co-stimulatory and co-inhibitory molecules that regulate cell function
- Markers of recent activation and effector function
- Compatible with the TokuKit – Teiko’s whole blood collection kit
-
T cells
- CD3
- Total T cells
- CD4
- CD4+ T cells
- CD8a
- CD8+ T cells
- CD27
- Maturation
- CD45RA
- Naive/Memory
- CCR7 (CD197)
- Naive/Memory
- Foxp3
- Treg
- CD25
- Treg, activation
- CD127
- T cell subsets
- T-bet
- T cell subsets
- CD38
- Maturation
- HLA-DR
- Activation
- TCF1
- Stemness
- CD7
- T cell subsets
- CD56
- NKT, T cell subsets
- gdTCR
- gdT cells
- CTLA-4 (CD152)
- Checkpoint
- PD-1
- Checkpoint
- TIM-3
- Checkpoint
- TIGIT
- Checkpoint
- LAG3
- Checkpoint
- CD161
- Inhibitory Receptor
-
B cells
- CD19
- Total B cells
- CD25
- Activation
- CD27
- Naive/Memory
- CD38
- Naive/Memory
- HLA-DR
- Antigen presentation
- CD74
- Antigen presentation
-
NK cells
- CD56
- NK cell subsets
- CD16
- NK cell subsets
- CD8a
- NK cell subsets
- CD7
- NK cell subsets
- CD38
- Activation
- T-bet
- Maturation
-
Myeloid cells
- CD11b
- Monocytes, macrophages
- CD11c
- Monocytes, macrophages, DCs
- CD14
- Monocyte subsets, Macrophages
- CD16
- Monocyte subsets
- CD33
- Total myeloid
- CD123
- pDC
- PD-L1
- Checkpoint ligand
- HLA-DR
- Antigen presentation
- CD86
- Antigen presentation
- LOX-1
- PMN-MDSCs
- CD74
- Antigen presentation
-
Granulocytes
Whole blood only- CD66b
- Granulocytes
- CD11b
- Neutrophils
- CD16
- Neutrophils
- CD15
- Neutrophils
- CD123
- Basophils
- FcER1
- Basophils, Mast cells
- cKit
- Mast cells
-
General
- CD45
- Total immune cells
- KI67
- Proliferation
- CD61
- Platelets
- CD235ab
- Erythrocytes
- DNA
- Singlets
- Live/Dead
- Viability
- IgG4
- Nivo/Pembro
- Siglec-8
- Cleanup gate
Up to 720+ Immune Subsets and States Analyzed
CLIA Validation Data
Mass Cytometry Assay for Pan-Immune Profiling of Whole Blood Collected with TokuKit-SHFill out the form below to access our CLIA Validation plan, report, data and SOPs.
Expertly Designed Human Pan-Immune PBMC Panel
The TokuProfile Standard Human Pan-Immune PBMC panel includes:
- Markers to identify every major immune cell population and subsets
- Expression of key co-stimulatory and co-inhibitory molecules that regulate cell function
- Markers of recent activation and effector function
-
T cells
- CD3
- Total T cells
- CD4
- CD4+ T cells
- CD8a
- CD8+ T cells
- CD27
- Maturation
- CD45RA
- Naive/Memory
- CCR7 (CD197)
- Naive/Memory
- Foxp3
- Treg
- CD25
- Treg, activation
- CD127
- T cell subsets
- T-bet
- T cell subsets
- CD38
- Maturation
- CD69
- Early Activation
- HLA-DR
- Activation
- CD56
- NKT, T cell subsets
- gdTCR
- gdT cells
- CTLA-4 (CD152)
- Checkpoint
- PD-1
- Checkpoint
- TIM-3
- Checkpoint
- TIGIT
- Checkpoint
- LAG3
- Checkpoint
- CD57
- Senescence
- KLRG-1
- Senescence
- Granzyme B
- Effector
- CD95
- Stem cell memory
- CD39
- Tumor specific
- CD28
- Co-stimulation, Maturation
- CD161
- Inhibitory Receptor
- ICOS
- Checkpoint
-
B cells
- CD19
- Total B cells
- CD25
- Activation
- CD27
- Naive/Memory
- CD38
- Naive/Memory
- HLA-DR
- Antigen presentation
-
NK cells
- CD56
- NK cell subsets
- CD16
- NK cell subsets
- CD8a
- NK cell subsets
- CD38
- Activation
- T-bet
- Maturation
- Granzyme B
- Effector
-
Myeloid cells
- CD11b
- Monocytes, macrophages
- CD11c
- Monocytes, macrophages, DCs
- CD14
- Monocyte subsets, Macrophages
- CD16
- Monocyte subsets
- CD33
- Total myeloid
- CD123
- pDC
- PD-L1
- Checkpoint ligand
- HLA-DR
- Antigen presentation
- LOX-1
- PMN-MDSCs
-
Granulocytes
Whole blood only- CD66b
- Granulocytes
- CD11b
- Neutrophils
- CD16
- Neutrophils
- CD15
- Neutrophils
- CD123
- Basophils
-
General
- CD45
- Total immune cells
- KI67
- Proliferation
- DNA
- Singlets
- Live/Dead
- Viability
- IgG4
- Nivo/Pembro
Up to 790+ Immune Subsets and States Analyzed
CLIA Validation Data
Mass Cytometry Assay for Pan-Immune Profiling of PBMCsFill out the form below to access our CLIA Validation plan, report, and data and SOPs.
25-Marker Human PBMC Pan-Immune Profiling Panel
Teiko Bio’s 25-Marker Spectral Flow Pan-Immune Profiling Test includes:
- Markers to identify every major immune cell population and subsets
- 6 functional state markers of maturation, activation, and exhaustion
- Gating performed by our team of expert immunologists
-
T cells
- CD3
- Total T cells
- CD4
- CD4+ T cells
- CD8
- CD8+ T cells
- CD25
- Treg, activation
- CD127
- T cell subsets
- CCR7
- Naive/Memory
- CD45RA
- Naive/Memory
- CD27
- Maturation
- CD28
- Maturation
- TCRgd
- gdT cells
- CD56
- NKT cells
- CD38
- Activation
- HLA-DR
- Activation
- PD-1
- Exhaustion
-
B cells
- CD19
- Total B cells
- CD20
- B cell subsets
- CD27
- Naive/Memory
- IgD
- B cell subsets
- IgM
- B cell subsets
- CD25
- Activation
- HLA-DR
- Antigen presentation
-
NK cells
- CD56
- NK cell subsets
- CD16
- NK cell subsets
- CD38
- Activation
-
Myeloid cells
- CD14
- Monocyte subsets
- CD16
- Monocyte subsets
- CD11c
- Monocytes, macrophages, DCs
- CD123
- pDC
- CD141
- cDC1
- CD1C
- cDC2
- HLA-DR
- Antigen presentation
-
Granulocytes
- CD123
- Basophil
-
General
- CD45
- Total immune cells
- ViaDye
- Viability
Up to 245 immune cell subsets and states
CLIA Validation Data
25-Marker Spectral Flow Pan-Immune Profiling Test for Human PBMCsFill out the form below to access our CLIA Validation plan, report, and data and SOPs.